Indi a Ste m Ce lls Ma rke t Fore ca st & O pport uni t i e s , 2020
P h a r m a & H e a l t h c a r e C o n s u l t a n t s
I n d u s t r y B r i e f
2
© Pharmaion
India Stem Cells Market to Grow at 28% through 2020
Growing presence of stem cells research centres, increasing consumer awareness and rising medical tourism isdriving Indian stem cells market
According to recently published Pharmaion report, “India Stem Cells Market Forecast & Opportunities,2020”, stem cells market in India is anticipated to grow at a CAGR of over 28% over 2015 - 2020. Growth inthe market is anticipated on account of increasing investments from the government as well as various privateorganizations, growing industry focus on stem cell research, and rising awareness about stem cell banking.Moreover, emergence of induced pluripotent stem (iPS) cells as an alternative to embryonic stem cells (ESCs),and evolution of new stem cell therapies are anticipated to boost growth in stem cells market in India over thenext five years.
Being considered as the “building blocks of life”, stem cells are capable of treating various diseases, such asdiabetes, multiple sclerosis, Parkinson's, Alzheimer's, arthritis, blindness, stroke and heart diseases. Moreover,scientists across the country are working on techniques to further enhance the efficacy of stem cell therapy. Forinstance, menstrual stem cell technology is a budding trend, which is capable of growing heart muscles at asuccess rate of more than 100 times higher than the 0.2-0.3% for stem cells taken from bone marrow. Thesecells can revolutionise the way many diseases are being treated and transform the lives of millions of peopleacross the country in the coming years.
On the basis of services offered, India stem cells market has been segmented into two categories, namely, stemcell banking and stem cell research. Stem cell research dominated the market in 2014, and is anticipated tocontinue its dominance during 2015 - 2020 on account of growing focus on commercialization of public andprivate research, rising number of stem cell research groups, and escalating cost for traditional drugdevelopment. In 2014, adult stem cells accounted for a majority share in the India stem cells market owing to alarge number of research being carried out using adult stem cells.
“Private stem cell banks are adopting various marketing tactics in order to increase their product visibility acrossthe country. Sales force of these private firms are visiting consumers and educating them about stem cellbanking concepts and associated advantages. Moreover, in India, the stem cell industry is witnessing increasinglevel of collaborations among the various stakeholders, which is positively impacting the stem cells market in thecountry.” said Mr. Karan Chechi, Research Director with Pharmaion, a research based global pharmaceutical andhealthcare consulting firm.
T a b l e o f C o n t e n t s
3
S No. Contents
1. Research Methodology
2. Analyst View
3. Product Overview
4. Global Stem Cell Market Overview
5. India Stem Cell Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Services
5.2.2. By Type
5.2.3. By Region
5.2.4. By Ownership
6. India Stem Cell Research Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
7. India Stem Cell Banking Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
© Pharmaion
T a b l e o f C o n t e n t s
4
S No. Contents
8. Market Dynamics
8.1. Drivers
8.2. Challenges
9. Market Trends & Developments
9.1. Medical Tourism
9.2. Dental Stem Cell Banking
9.3. Menstrual Blood Stem Cell Banking
9.4. New Marketing Concepts
9.5. Collaborations & Partnerships
10. SWOT Analysis
11. Policy & Regulatory Landscape
12. India Economic Profile
13. Competition Landscape
13.1. Competition Matrix
13.2. Company Profiles
13.2.1. LifeCell International Pvt. Ltd
13.2.2. Reliance Life Sciences Pvt. Ltd.
13.2.3. Cryobanks International India Pvt. Ltd.
13.2.4. CordLife Sciences India Pvt. Ltd.
13.2.5. Cryo-Save (India) Private Limited
13.2.6. Stemade Biotech Pvt. Ltd.
13.2.7. Institute for Stem Cell Biology and Regenerative Medicine (inStem)© Pharmaion
T a b l e o f C o n t e n t s
5
S No. Contents
13.2.8. Nichi-In Centre for Regenerative Medicine
13.2.9. TranScell Biologics Pvt. Ltd.
13.2.10. EmProCell Clinical Research Private Limited
14. Strategic Recommendations
15. About Us & Disclaimer
© Pharmaion
R e s e a r c h M e t h o d o l o g y
6
Baseline Methodology:
For the study, Pharmaion has gathered information through primary research with respondents in stem cell banking
and research companies across India, followed by external validation of the information by interviewing
distributors. We also gathered insights through exhaustive search of credible paid databases and our internal
database. Our team of analysts has then prudently evaluated all the collected information and presented it in
chronological order to depict a meaningful and comprehensible picture of India stem cells market.
While compiling the data, we have also validated all the collected information from multiple sources and data
warehouses, in order to present accurate and precise information of the concerned industry. The same information
has then been verified through primary research surveys with competitors to arrive at logical figures.
Manufacturers Interviewed
Nichi-In Centre for Regenerative Medicine, LifeCell International Pvt. Ltd., Reliance Life Sciences Pvt. Ltd., L V
Prasad Eye Institute, inStem, Cryobanks International India Pvt. Ltd., EmProCell Clinical Research Private Limited,
TranScell Biologics PVT.,LTD.
Sources: Company Websites, The National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT),
Indian Council of Medical Research (ICMR) and Department of Biotechnology (DBT)
© Pharmaion
S a m p l e D a t a - S n a p s h o t
7
© Pharmaion
13
57
913
1517
1921 23
2010 2011 2012 2013 2014 2015E2016F2017F2018F2019F2020F
India Stem Cells Market Size, By
Value, 2010-2020F (USD Million)
38.00%38.10%38.20%38.30%38.40%38.50%38.60%38.70%38.80%38.90%39.00%
60.00%60.10%60.20%60.30%60.40%60.50%60.60%60.70%60.80%60.90%61.00%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Stem Cell Banking Stem Cell Research
India Stem Cells Market Share, By Service, By Value, 2010-2020F
Hematopoietic & Bone Marrow,
10%
Neuronal, 10%
Mesenchymal, 10%
Liver, 10%
Pancreatic Progenitor Cells, 10%
Limbal, 10%
Cardiac, 10%
Retinal, 10%
Muscle, 10% Cancer, 10%
India Adult Stem Cells Market
Share, By Type, By Value, 2014
3.00% 3.10% 3.20% 3.30% 3.40% 3.50% 3.60% 3.70% 3.80% 3.90% 4.00%
28.00%28.10%28.20%28.30%28.40%28.50%28.60%28.70%28.80%28.90%29.00%
30.00%30.10%30.20%30.30%30.40%30.50%30.60%30.70%30.80%30.90%31.00%
33.00%33.10%33.20%33.30%33.40%33.50%33.60%33.70%33.80%33.90%34.00%
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
South
West
North
Others
India Stem Cells Market Share, By Region, By Value, 2010-2020F
Average Cost of Stem Cell Banking
in India (USD)
Cord Stem Cell Banking
X
Dental Stem Cell Banking
X
Bone Marrow Stem Cell Banking
X
Menstrual Blood Stem Cell Banking
X
Adipose Tissue Stem Cell Banking
X
India Stem Cells Banking Market Size, By
Value, 2010-2020F (USD Million)
13
57
913
1517
1921
23
2010 2011 2012 2013 2014 2015E 2016F 2017F 2018F 2019F 2020F
Indicators India
Diabetes cases X (million) X
Undiagnosed diabetes cases X
(million)X
Diabetes national prevalence (X%) X
Diabetes comparative prevalence
(X%)X
Diabetes related deaths X (million) X
Cost/person with diabetes (X) X
India Summary of Diabetes Indicators, 2014
R e p o r t O r d e r i n g
8
© Pharmaion
License Type Price
Single User License $3000
Single User License Print $3500
Enterprise License $6000
To View Sample OR Purchase Report
Report Price
Report Name: India Stem Cells Market Forecast and
Opportunities, 2020
A b o u t U s & D i s c l a i m e r
9
© Pharmaion
NORTH AMERICA
Pharmaion Consultants LLC
708 3RD Avenue, 6th Floor, New York, NY,
United State, 10017
+1 646 360 1656
www.pharmaion.com
About Us :
Pharmaion is a research based management consulting firm focused exclusively on Healthcare & Pharmaceutical industry.
Pharmaion’s core values are value, integrity and insight. Led by a team of dynamic industry experts, Pharmaion provides its customers
with high value market research and advisory services that helps them identify new market opportunities, growth engines andinnovative ways to capture the market share. As a result, Pharmaion’s clients lead rather than follow market trends. Not bound bylegacy, Pharmaion’s cutting-edge research model leverages its decades of research knowledge and an increased use of technology as
engines of innovation to deliver unique research value. Provided as an alternative to traditional market research, Pharmaion’s reportsdo not just deliver data and knowledge rather highlights the insights in a more usable and interactive format for its clients.
Pharmaion is committed to assisting customers worldwide with their unique market research needs by providing them withcomprehensive, value-added solutions and professional market intelligence services. Pharmaion employs the industry’s best-trained
industry Analysts and Consultants, which advises and assists customers in meeting their full service market research and consultingrequirements.
Related Reports
India Hospitals Market Forecast & Opportunities, 2020
Global Tissue Engineered Medical Devices Market Forecast & Opportunities, 2020
Global Cervical Cancer Vaccine Market Forecast & Opportunities, 2020
Disclaimer :The contents of this report are based on information generally available to the public from sources believed to be reliable. No representation is madethat it is timely, accurate or complete. Pharmaion Consultants has taken due care and caution in compilation of data as this has been obtained fromvarious sources including which it considers reliable and first hand. However, Pharmaion Consultants does not guarantee the accuracy, adequacy orcompleteness of any information and it is not responsible for any errors or omissions or for the results obtained from the use of such information andespecially states that it has no financial liability whatsoever to the subscribers / users of this report. The information herein, together with all estimatesand forecasts, can change without notice. All the figures provided in this document are indicative of relative market size and are strictly for client’sinternal consumption. Usage of the same for purpose other than internal will require prior approval of Pharmaion Consultants.
ASIA-PACIFIC
Pharmaion Consultants Pvt. Ltd.
A – 51, Sector 57, Noida, National Capital Region,
India - 201301
+91 - 120 - 452 3900
www.pharmaion.com